US 11771762
Anti-ErbB3 antibodies and uses thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11771762 (Anti-ErbB3 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K31/517, A61K31/5377